The presence of supernumerary centrosomes is prevalent in cancer, where they promote the formation of transient multipolar mitotic spindles. Active clustering of supernumerary centrosomes enables the formation of a functional bipolar spindle that is competent to complete a bipolar division. Disruption of spindle pole clustering in cancer cells promotes multipolar division and generation of non-proliferative daughter cells with compromised viability. Hence molecular pathways required for spindle pole clustering in cells with supernumerary centrosomes, but dispensable in normal cells, are promising therapeutic targets. Here we demonstrate that Aurora A kinase activity is essential for spindle pole clustering in cells with extra centrosomes. While cells with two centrosomes are ultimately able to build a bipolar spindle and proceed through a normal cell division in the presence of Aurora A inhibition, cells with supernumerary centrosomes form multipolar and disorganized spindles that are not competent for chromosome segregation. Instead, following a prolonged mitosis, these cells experience catastrophic divisions that result in grossly aneuploid, and non-proliferative daughter cells. Aurora A inhibition in a panel of Acute Myeloid Leukemia cancer cells has a similarly disparate impact on cells with supernumerary centrosomes, suggesting that centrosome number and spindle polarity may serve as predictive biomarkers for response to therapeutic approaches that target Aurora A kinase function.
Introduction
The formation of a mitotic spindle with two spindle poles is integral to proper chromosome segregation. During mitosis a pair of centrosomes, the microtubule nucleating and organizing centers of the cell, serve as focal points at which molecular motors and crosslinkers cluster microtubules (reviewed in (1) and (2)). In cancer, centrosome amplification is common, where it contributes to aneuploidy, and is correlated with high tumor grade and poor patient prognosis (3) (4) (5) (6) (7) . A direct consequence of having more than two centrosomes is the capacity to form a mitotic spindle with more than two spindle poles (8) . Multipolar divisions that can result from such spindle geometry, lead to daughter cells with dramatic changes in chromosome number, and decreased viability (5, 9) . To limit multipolar divisions, cells with excess centrosomes actively cluster excess centrosomes into functional bipolar spindles (7, (10) (11) (12) (13) . Cells with clustered centrosomes complete bipolar anaphases with only moderate chromosome segregation errors, and remain viable (8, 14) . In this way, the molecular players involved in centrosome clustering have an important role in determining the fate of cancer cells with supernumerary centrosomes and are therefore attractive candidates for therapeutic approaches (11, 15) . Aurora A (AurA) is a serine/threonine kinase that is important for proper bipolar spindle formation. Localized to the centrosome during interphase and to spindle poles during mitosis, AurA phosphorylates protein targets to regulate centrosome maturation and spindle assembly such that loss of AurA kinase-dependent phosphorylation of key mitotic targets disrupts mitotic spindle formation (16, 17) . Some targets of AurA kinase, including Eg5, contribute to spindle formation by promoting anti-poleward forces that push centrosomes apart (18, 19) . Other targets of AurA kinase, including TACC, have roles in stabilizing microtubule dynamics and promoting spindle pole organization (20) (21) (22) .
Interestingly, inhibition of AurA kinase activity has been shown to both impair separation of spindle poles to result in spindle pole collapse and formation of a single monopole (23) (24) (25) , and alternatively to promote spindle disorganization (26) (27) (28) . Nevertheless, the underlying cause of this disparate response to AurA inhibition remains unclear.
Here we show that the response to AurA kinase inhibition is influenced by centrosome number and the capacity to form multipolar spindles during mitosis. Inhibition of AurA kinase activity in cells with normal centrosome content induces a transient mitotic spindle pole collapse that ultimately resolves to enable a bipolar division and sustained proliferation. In contrast, AurA kinase activity is essential in cells with supernumerary centrosomes such that AurA inhibition here compromises centrosome clustering, promotes abortive cell division, and results in multinucleated, highly aneuploidy daughter cells with reduced proliferative capacity. Together, these findings suggest that therapeutic approaches that exploit AurA inhibition will be most advantageous in cancers with supernumerary centrosomes.
Results

AurA promotes clustering of supernumerary centrosomes
To explore the relationship between spindle polarity and response to AurA inhibition we utilized two experimental systems to manipulate centrosome number. First, we induced supernumerary centrosomes using a previously characterized human epithelial cell line carrying a doxycycline-regulated PLK4 expression construct (indPLK4) (8) . PLK4 is a regulator of centrosome biogenesis that when overexpressed leads to a cell-cycle dependent over-duplication of centrosomes (Supplemental Figure 1A & B ). In the absence of PLK4 induction, the hTERT-immortalized human retinal pigment epithelial (RPE) cell line is diploid, contains a single pair of centrioles (one centrosome) during interphase that is duplicated in preparation for mitosis, and forms a bipolar mitotic spindle. Following induction of PLK4 overexpression for 36h, the majority of RPE cells have 8+ centrioles, as indicated by centrin-2 staining, and exhibit an increased frequency of multipolar spindles ( Figure 1A and 1B). In a second, complementary approach, the near-diploid HCT116 colon cancer cell line was treated with Cytochalasin B (CytoB) to induce cytokinesis failure. The resulting cells have double the DNA content and double the centrosome number, and an increased incidence of multipolar mitotic spindles, independent of PLK4 expression level ( Figure 1C and 1D). Alisertib (MLN8237) is an orally bioavailable inhibitor of AurA kinase that is ~200 fold more selective for AurA than the closely related Aurora B (29). Pharmacological inhibition of AurA kinase activity can be monitored through loss of AurA auto-phosphorylation of threonine residue 288 in its activation loop (30). We show that 100nM alisertib is sufficient to inhibit AurA kinase activity and prevent threonine 288 phosphorylation (p-AurA) similarly in both control cells, and those with centrosome amplification ( Figure 1E ). 
Cell fate in the presence of AurA inhibition is influenced by centrosome number
Regardless of centrosome number, following extended AurA inhibition, mitotic enrichment does not surpass ~10% of the cell population ( Figure 1F ), suggesting that mitotic defects For the >40% of cells with supernumerary centrosomes that are unable to complete a bipolar division in the presence of AurA inhibition, mitotic exit is catastrophic. In agreement with the high incidence of multipolar and disorganized spindles seen in fixed cell analysis (Figure 1 ), many cells with supernumerary centrosomes exit mitosis via a multipolar or abortive division. Consistent with previous reports (8, 14) , we find the progeny of multipolar divisions exhibit decreased proliferative capacity and decreased viability. Cells that instead undergo an abortive mitosis attempt cytokinesis in the absence of metaphase alignment and anaphase segregation (Figure 2A . Importantly, none of the cells that experienced multipolar or abortive mitotic divisions were competent to reenter the cell cycle within the duration of our movies, contributing to a 40% decrease in proliferation of cells with supernumerary centrosomes following AurA inhibition ( Figure   2D ).
Centrosome number corresponds with response to Aurora A inhibition
To determine if centrosome number similarly corresponds with response to AurA inhibition in a cancer cell context we utilized a panel of Acute Myeloid Leukemia (AML) cells. AML is a cancer context where AurA kinase is often amplified, and where its inhibition is actively being exploited in preclinical and clinical approaches (31-33).
Western blot and qPCR analyses demonstrate that AurA expression in these cell lines, independent of cell cycle distribution, range from levels comparable to that of the nontransformed RPE cell line (ie HL60), to levels over 8-fold higher that that seen in RPE-1 cells (ie K562) ( Figure 4A & 4B, Supplemental Figure 2A ). Importantly, irrespective of AurA protein level, exposure to 100nM alisertib was sufficient to completely inhibit AurA kinase activity, as judged by AurA auto-phosphorylation ( Figure 4B ), and similarly resulted in a dose-dependent enrichment of mitotic cells in all AML cell lines ( Figure 4E and Supplemental Figure 2B ).
Immunofluorescence analysis of centrin-2 indicated that over 70% of interphase U937 and K562 cells contain more than one centrosome (2 centrioles) ( Figure 4C & D) . Nevertheless, mitotic spindles in each cell line are predominantly bipolar, indicating that these cells can efficiently cluster supernumerary centrosomes (data not shown). As seen with the RPE and HCT116 cells, inhibition of AurA promotes spindle pole collapse in AML cells with two centrosomes (HL60, THP1, KG1a), and a multipolar or disorganized spindle phenotype in AML cells with supernumerary centrosomes (K562) ( Figure 4F ). Consistent with the abortive mitoses seen following experimental induction of supernumerary centrosomes in RPE cells, FACXs analysis indicate that AML cells with supernumerary centrosomes and disorganized spindles also exhibit an increased DNA content following AurA inhibition ( Figure 4G ).
Discussion
Our data support a model whereby the presence of extra centrosomes, acquired either through over-duplication or previous failed cytokinesis, can alter the response of cells to inhibitors of mitotic spindle assembly and subsequently impact the efficacy of such drugs.
We find that following AurA inhibition, cells with supernumerary centrosomes exhibit multipolar and disorganized spindles that cannot be resolved prior to mitotic exit. Instead, such cells are subject to abortive mitoses where cytokinesis is attempted in the absence of Together with cell biological evidence that inhibition of AurA compromises mitotic progression, an increased Aurora A expression profile in cancer supports that AurA is a clinically relevant drug target (44) . Pharmaceutical companies have begun to exploit this possibility, bringing numerous targeted inhibitors to the market as anti-cancer drugs, and spurring clinical trials (33, [45] [46] [47] [48] [49] [50] [51] . However, while the efficacy and safety of inhibiting AurA have been supported by preclinical and early stage clinical trials, response to AurA inhibition has been limited (33, 51-53) and it remains unclear which patients may best benefit from Aurora A inhibitor treatment either alone, or in combination with standard chemotherapeutic approaches. We now show that cells with extra centrosomes are susceptible to catastrophic cell divisions when AurA activity is inhibited. Furthermore, consistent with the documented tolerance of patients to AurA inhibitors in the clinic (33, 52, 54) , our data demonstrate that normal cells with two centrosomes are not susceptible to the mitotic catastrophe and abortive divisions that are induced in cancer cells with supernumerary centrosomes. Together, these findings suggest that AurA inhibition can selectively corrupt proliferation of cancer cells with extra centrosomes, and that clinical assessment of mitotic structures may be useful in identifying patients most likely to benefit from their use.
Materials and Methods
Cell culture, induction, and inhibition:
Cells were grown in DMEM/F12 medium (RPE-1) or RPMI 1640 medium (HL60, K562, KG1a, THP1, and U937) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin and maintained at 37C with 5% CO2. For experiments where PLK4 expression was induced, media was supplemented with 2 µg/mL Doxycycline for 36 hours.
Alternatively, cells were treated with 30 µM Cytochalasin B for 16h to induce cytokinesis failure and generate tetraploid cells with double the normal centrosome number (8) . Drug treatments to subsequently inhibit AurA kinase (alisertib; MLN8054, Aurora A inhibitor 1, MK-5108 (VX-689): Selleckchem) were performed at the indicated concentrations for 16-18 hours for immunofluorescence and FACs analysis, or as otherwise indicated. Unless otherwise noted, all experiments to inhibit Aurora A kinase were performed with the highly specific Aurora A kinase inhibitor alsiertib at a concentration of 100nM.
FACS and expression analysis
To assess cell cycle differences and response to mitotic inhibitors, cells were treated with 100 ng/mL Nocodazole (to induce mitotic arrest) and/or 100 nM alisertib for 16-18 hours, fixed and stained with propidium iodide, and processed for FACs analysis as previously described (55) . To assess AurA expression levels, RNA extraction was performed with 
FISH, Immunofluorescence and live cell imaging
Cells were prepared and fixed as described previously (55) and a-satellite probes for chromosomes 6 and 8 hybridized to chromatin. Numerical Heterogeneity (NH) was determined by scoring a minimum of 500 cells per population for copy number of each chromosome probe, for each of three independent experiments. Percent variation from the modal copy number was calculated and compared across conditions. For immunofluorescence imaging, cells were cultured on glass coverslips (RPE), or spun onto coverslips by centrifugation at 1000 RPM for 3 minutes (AML cell lines) prior to fixation for 10 min in ice-cold methanol, blocked in TBS-BSA (10mM Tris at pH 7.5, 150mM
NaCl, 1% bovine serum albumin), and stained for a-tubulin (dm1a, Sigma), and/or centrin-2 (Santa Cruz) as indicated. DNA was detected with 0.2µg/mL DAPI (Sigma), and coverslips mounted with Prolong Antifade Gold mounting medium (Molecular Probes). 
